ArticleScientific reports2017

HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy.

Antonella Mangraviti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.